Entos is now Iambic Therapeutics
Read more
Platform
Pipeline
Partnerships
News & Media
About
Careers
Contact
Contact
Presentations
back to blog
Caltech Heritage Project: A profile on Tom Miller, CEO of Iambic
Presentations
This is some text inside of a div block.
June 1, 2022
Media Contacts
Related announcements
View All
View All
April 8, 2024
Podcast Discusses New Advances for Iambic's Clinical Oncology Study and its AI-Driven Drug Discovery Platform
Read more
April 8, 2024
Podcast Discusses New Advances for Iambic's Clinical Oncology Study and its AI-Driven Drug Discovery Platform
Read more
April 5, 2024
Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Read more
April 5, 2024
Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Read more
March 28, 2024
Iambic Therapeutics to Present New Pre-Clinical Data for IAM1363, a Selective and Brain-Penetrant Inhibitor of both HER2 Wild-Type and Oncogenic Mutants, at the 2024 AACR Annual Meeting
Read more
March 28, 2024
Iambic Therapeutics to Present New Pre-Clinical Data for IAM1363, a Selective and Brain-Penetrant Inhibitor of both HER2 Wild-Type and Oncogenic Mutants, at the 2024 AACR Annual Meeting
Read more